https://www.selleckchem.com/
24; 95% CI, 1.17-1.32; 0.00001) and presents advantages in increasing leukocyte count (MD, 1.10; 95% CI, 0.67-1.53; 0.00001). Also, the statistical results show that AMT performs better in improving the CIL patients' Karnofsky performance score (MD, 5.92; 95% CI, 3.03-8.81; 0.00001). This systematic review and meta-analysis provides updated evidence that AMT is a safe and effective alternative for the patients who suffered from CIL. This systematic review and meta-analysis provides updated evidence that AMT is a safe and effective alternative
Like
Comment
Share
